← Back to Search

Behavioural Intervention

Loss-framed Messaging for Alcohol Consumption (GLOSS Trial)

N/A
Recruiting
Led By Alexis Kuerbis, LCSW, PhD
Research Sponsored by Hunter College of City University of New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 4, week 8, and week 16
Awards & highlights

GLOSS Trial Summary

This trial aims to test different text-messaging programs to help older adults reduce their alcohol use. The study will compare messages that focus on the negative consequences of not changing behavior to messages that highlight the benefits

Who is the study for?
This trial is for older adults aged 50-85 who drink more than the recommended amount per week, own a mobile phone with SMS, and have an email address. They must want to cut down their drinking to safer levels, be fluent in English at least at the eighth grade level, and agree to receive/respond to many texts and complete online surveys.Check my eligibility
What is being tested?
The study tests three text-messaging programs designed to reduce alcohol use among older adults by framing messages around the benefits of reducing drinking (gain-framed) or consequences of not changing (loss-framed). Participants will get one type of message over eight weeks and track their drinking through assessments.See study design
What are the potential side effects?
Since this trial involves text messaging interventions without medications or medical procedures, there are no direct physical side effects. However, participants may experience stress or anxiety related to changing their drinking habits.

GLOSS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 4, week 8, and week 16
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 4, week 8, and week 16 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Weekly sum of heavy drinking days
Weekly sum of standard drinks
Secondary outcome measures
Percent adherence to daily drinking assessment via text messages
Percent adherence to weekly drinking assessment via web
Percent willingness to continue the program for another 8 weeks

GLOSS Trial Design

3Treatment groups
Active Control
Group I: Loss-framed MessagingActive Control2 Interventions
Daily text messages on the consequences of hazardous drinking (e.g., "Think of all you have lost as a result of drinking too much. Make today a day that sets the stage for change.")
Group II: Gain-framed MessagingActive Control2 Interventions
Daily text messages on the benefits of reducing drinking to safe guidelines (e.g., "Think of all you can achieve if you can control your drinking. Make today a day that sets the stage for change.")
Group III: Gain-framed and Loss-framed MessagingActive Control3 Interventions
Daily text messages that alternate between loss-framed (e.g., "Think of all you have lost as a result of drinking too much. Make today a day that sets the stage for change.") and gain-framed messaging (e.g., "Think of all you can achieve if you can control your drinking. Make today a day that sets the stage for change.")

Find a Location

Who is running the clinical trial?

Hunter College of City University of New YorkLead Sponsor
38 Previous Clinical Trials
8,885 Total Patients Enrolled
Alexis Kuerbis, LCSW, PhDPrincipal InvestigatorSilberman School of Social Work at Hunter College City, University of New York

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of individuals actively participating in this clinical research?

"Affirmative. Information on clinicaltrials.gov affirms the current recruitment status of this clinical trial. It was initially posted on February 26, 2024, and last revised on March 28, 2024. The study aims to enroll a total of 150 participants from one designated research site."

Answered by AI

Are there still available slots for patients to participate in this ongoing clinical trial?

"Yes, as per details on clinicaltrials.gov, this clinical investigation is presently seeking potential participants. The trial was initially posted on February 26th, 2024 and most recently revised on March 28th, 2024. Enrolment entails recruiting a total of 150 individuals from one designated site."

Answered by AI

Does this research include individuals above the age of 25?

"To partake in this investigation, individuals must fall within the age range of 50 to 85 years. It is worth noting that there are 25 clinical trials designated for patients under 18 and a total of 191 studies tailored for those above 65 years old."

Answered by AI
~37 spots leftby Jul 2024